Targeting the DNA Damage Response for Anti-Cancer Therapy
Over the past decade a complex role for DNA damage response (DDR) in tumorigenesis has emerged. A proficient DDR has been shown to be a primary cause for cellular resistance to the very many DNA damaging drugs, and IR, that are widely used as standard-of-care across multiple cancer types. It has als...
| Corporate Author: | SpringerLink (Online service) |
|---|---|
| Other Authors: | Pollard, John (Editor, http://id.loc.gov/vocabulary/relators/edt), Curtin, Nicola (Editor, http://id.loc.gov/vocabulary/relators/edt) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Humana,
2018.
|
| Edition: | 1st ed. 2018. |
| Series: | Cancer Drug Discovery and Development,
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Similar Items
-
Digestive System Diseases Stem Cell Mechanisms and Therapies /
Published: (2019) -
Clinical Epigenetics
Published: (2019) -
Herbs for Cancer Treatment
by: Koul, Bhupendra, et al.
Published: (2019) -
Human Epigenetics: How Science Works
by: Carlberg, Carsten, et al.
Published: (2019) -
Hereditary Colorectal Cancer Genetic Basis and Clinical Implications /
Published: (2018)